Mason Morfit

ValueAct returns to Valeant board, plans to raise stake

Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in the company.

Read Full Article

Microsoft investor, Mason Morfit seeks change on how giant software maker sells its products

ValueAct Holdings President Mason Morfit plans to influence Microsoft on how it sells Windows, the operating system that is behind most of the software giant's products, Bloomberg reported.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics